You Searched For:
4 111 results were found
Workflow für die biopharmazeutische Medienvorbereitung von Masterflex
/cms/media-prep
Medienzubereitung + Pumpen Pumpen L/S Digital Edelstahlpumpe bis zu 34 LPM I/P Digital Edelstahlpumpe bis zu 13 LPM B/T Digital Edelstahlpumpe bis zu 42 LPM L/S Precision Edelstahlpumpe bis zu 34 LPM + Filtrationsprodukte Filtrationsprodukte Ob Vo...
Biopharma events:
/cms/biopharma_exhibition_event
Biopharma events: Meet our specialists at the major Biopharma events! Learn more about VWR Bioprocessing Solutions and what we can do for you ... Learn more about VWR Single-Use-Solutions ... Subscribe for the VWR Newsletter Cell&Gene Therapy Manu...
Workflow für die biopharmazeutische Medienvorbereitung von Masterflex
/cms/fr/media-prep
Medienzubereitung + Pumpen Pumpen L/S Digital Edelstahlpumpe bis zu 34 LPM I/P Digital Edelstahlpumpe bis zu 13 LPM B/T Digital Edelstahlpumpe bis zu 42 LPM L/S Precision Edelstahlpumpe bis zu 34 LPM + Filtrationsprodukte Filtrationsprodukte Ob Vo...
Hichrom International Catalogue 9 33 57
/m-at.vwr.com/de_AT/images/Hichrom_International_Catalogue_9_33_57.pdf
33 LC Colum n Selection – C18 Reversed-Phase M aterials www.hichrom.co.uk • sales@hichrom.co.uk • Tel: +44 (0) 118 930 3660 Hichrom Lim ited C18 Reversed-Phase Materials SPECIFICATIONS OF C18 BONDED RP MATERIALS Octadecyl (ODS) or C18 bonded phase...
Hichrom International Catalogue 9 33 57
/m-be.vwr.com/nl_BE/images/Hichrom_International_Catalogue_9_33_57.pdf
33 LC Colum n Selection – C18 Reversed-Phase M aterials www.hichrom.co.uk • sales@hichrom.co.uk • Tel: +44 (0) 118 930 3660 Hichrom Lim ited C18 Reversed-Phase Materials SPECIFICATIONS OF C18 BONDED RP MATERIALS Octadecyl (ODS) or C18 bonded phase...
Hichrom International Catalogue 9 33 57
/m-ch.vwr.com/fr_CH/images/Hichrom_International_Catalogue_9_33_57.pdf
33 LC Colum n Selection – C18 Reversed-Phase M aterials www.hichrom.co.uk • sales@hichrom.co.uk • Tel: +44 (0) 118 930 3660 Hichrom Lim ited C18 Reversed-Phase Materials SPECIFICATIONS OF C18 BONDED RP MATERIALS Octadecyl (ODS) or C18 bonded phase...
Hichrom International Catalogue 9 33 57
/m-us.vwr.com/en_US/images/Hichrom_International_Catalogue_9_33_57.pdf
33 LC Colum n Selection – C18 Reversed-Phase M aterials www.hichrom.co.uk • sales@hichrom.co.uk • Tel: +44 (0) 118 930 3660 Hichrom Lim ited C18 Reversed-Phase Materials SPECIFICATIONS OF C18 BONDED RP MATERIALS Octadecyl (ODS) or C18 bonded phase...
Hichrom International Catalogue 9 33 57
/m-ch.vwr.com/de_CH/images/Hichrom_International_Catalogue_9_33_57.pdf
33 LC Colum n Selection – C18 Reversed-Phase M aterials www.hichrom.co.uk • sales@hichrom.co.uk • Tel: +44 (0) 118 930 3660 Hichrom Lim ited C18 Reversed-Phase Materials SPECIFICATIONS OF C18 BONDED RP MATERIALS Octadecyl (ODS) or C18 bonded phase...
Biopharma events:
/cms/biopharma_exhibition_event
Biopharma events: Meet our specialists at the major Biopharma events! Learn more about VWR Bioprocessing Solutions and what we can do for you ... Learn more about VWR Single-Use-Solutions ... Subscribe for the VWR Newsletter Cell&Gene Therapy Manu...
Workflow für die biopharmazeutische Medienvorbereitung von Masterflex
/cms/it/media-prep
Medienzubereitung + Pumpen Pumpen L/S Digital Edelstahlpumpe bis zu 34 LPM I/P Digital Edelstahlpumpe bis zu 13 LPM B/T Digital Edelstahlpumpe bis zu 42 LPM L/S Precision Edelstahlpumpe bis zu 34 LPM + Filtrationsprodukte Filtrationsprodukte Ob Vo...
A18L14A UHP SEC analysis of biosimilars
/m-fi.vwr.com/fi_FI/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-be.vwr.com/nl_BE/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-be.vwr.com/fr_BE/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-nl.vwr.com/nl_NL/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-ni.vwr.com/en_NI/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
A18L14A UHP SEC analysis of biosimilars
/m-cz.vwr.com/cs_CZ/images/A18L14A_UHP_SEC_analysis_of_biosimilars.pdf
ANALYSIS APPLICATION NOTE INTRODUCTION A biosimilar is a biological medicine highly similar to an approved biological medicine (originator) in terms of structure biological activity and efficacy safety and immu- nogenicity profile. In order to dem...
81 - 96 of 4 111